Carregant...
What is the future of ribavirin therapy for hepatitis C?
With the introduction of direct-acting antiviral (DAA) therapy against hepatitis C virus (HCV) infection, the field is rapidly evolving towards interferon-free regimens with high sustained virologic response (SVR) rates. The ultimate goal of therapy in chronic HCV infection should include an easily...
Guardat en:
| Publicat a: | Antiviral Res |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6299454/ https://ncbi.nlm.nih.gov/pubmed/24468277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2014.01.005 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|